Premature Ovarian Failure and the FMR1 Gene

Anna Murray

doi:10.1055/s-2000-13476

Seminars in Reproductive Medicine, Inhaltsverzeichnis

Semin Reprod Med 2000; 18(1): 059-066
DOI: 10.1055/s-2000-13476

Premature Ovarian Failure and the FMR1 Gene

Anna Murray

University of Southampton, Human Genetics Research Division, Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, Wiltshire, United Kingdom

Abstract

ABSTRACT

FMR1 is an X-linked gene that codes for an RNA binding protein. Expansion of a triplet repeat within exon 1 of the gene causes the fragile X syndrome, which is characterized by mental retardation and various physical anomalies. The triplet repeat in FMR1 can expand to varying degrees. Only the very large expansions in which there is concomitant methylation of the gene cause the fragile X syndrome. Expansions of between 50 and 200 repeats are premutations. Although premutations were originally perceived to be without phenotypic effect, there is now substantial evidence that female carriers of premutations are at increased risk of having early menopause. The FMR1 premutation is also associated with a significant number of cases ascertained because of idiopathic premature ovarian failure, particularly when ovarian failure is a familial trait. The molecular mechanism to explain the association between ovarian failure and premutations is unknown.

KEYWORD

premature ovarian failure - premutation

Volltext

Referenzen

REFERENCES

1 McKinlay S, Jefferys M, Thompson B. An investigation of the age at menopause. J Biosoc Sci . 1972; 4 161-173
2 Coulam C B, Adamson S C, Annegers J F. Incidence of premature ovarian failure. Obstet Gynecol . 1986; 67 604-606
3 Vegetti W, Tibiletti M G, Testa G. Inheritance in idiopathic premature ovarian failure: analysis of 71 cases. Hum Reprod . 1998; 13 1796-1801
4 van Kasteren M Y, Hundscheid R DL, Smits A PT, Cremers F PM, van Zonneveld P, Braat D DM. Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease?. Hum Reprod . 1999; 14 2455-2459
5 Wyss D, DeLozier C D, Daniell J, Engel E. Structural anomalies of the X chromosome: personal observation and review of non-mosaic cases. Clin Genet . 1982; 21 145-159
6 Davi A, Benn P A. X-chromosome abnormalities in women with premature ovarian failure. J Reprod Med . 1999; 44 321-324
7 Lippe B. Puberty and its disorders: Turner syndrome. Endocrinol Metab Clin North Am . 1991; 20 121-152
8 Ogata T, Matsuo N. Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features. Hum Genet . 1995; 95 607-629
9 Marschio P, Tupler R, Barbierato L. Analysis of Xq deletions. Hum Genet . 1996; 97 375-382
10 Powell C M, Taggart R T, Drumheller T C. Molecular and cytogenetic studies of an X: autosome translocation in a patient with premature ovarian failure and review of the literature. Am J Med Genet . 1994; 52 19-26
11 Therman E, Laxova R, Susman B. The critical region on the human Xq. Hum Genet . 1990; 85 455-461
12 Sala C, Arrigo G, Torri G. Eleven X chromosome breakpoints associated with premature ovarian failure (POF) map to a 15-Mb YAC contig spanning Xq21. Genomics . 1997; 40 123-131
13 Aittomaki K, Lucena J LD, Pakarinen P. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell . 1995; 82 959-969
14 Bione S, Sala C, Manzini C. A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Am J Hum Genet . 1998; 62 533-542
15 Verkerk A M H J, Pieretti M, Sutcliffe J S. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell . 1991; 65 905-914
16 Ashley Jr T C, Warren S T. Trinucleotide repeat expansion and human disease. Annu Rev Genet . 1995; 29 703-728
17 Hinds H L, Ashley C T, Sutcliffe J S. Tissue specific expression of FMR-1 provides evidence for a functional role in fragile-X syndrome. Nat Genet . 1993; 3 36-43
18 Tamanini F, Meijer N, Verheij C. FMRP is associated to the ribosomes via RNA. Hum Mol Genet . 1996; 5 809-815
19 Eichler E E, Richards S, Gibbs R A, Nelson D L. Fine structure of the human FMR1 gene. Hum Mol Genet . 1993; 2 1147-1153
20 Sutherland G R, Richards R I. Simple tandem DNA repeats and human genetic disease. Proc Natl Acad Sci U S A . 1995; 92 3636-3641
21 Jacobs P A, Bullman H, Macpherson J. Population studies of the fragile(X): a molecular approach. J Med Genet . 1993; 30 454-459
22 Brown W T, Nolin S, Houck G. Prenatal diagnosis and carrier screening for fragile X by PCR. Am J Med Genet . 1996; 64 191-196
23 Murray A, Youings S, Dennis N. Population screening at the FRAXA and FRAXE loci: molecular analyses of boys with learning difficulties and their mothers. Hum Mol Genet . 1996; 5 727-735
24 Roussaeu F, Heitz D, Biancalana V. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med . 1991; 325 1673-1681
25 Youings S A, Murray A, Dennis N. FRAXA and RAXE: the results of a five year survey. J Med Genet . 2000; 37 415-421
26 Sutherland G R, Mulley J C. Fragile X syndrome and fragile XE mental retardation. Prenat Diagn . 1996; 16 1199-11211
27 Bell M V, Hirst M C, Nakahori Y. Physical mapping across the fragile X: hypermethylation and clinical expression of the fragile X syndrome. Cell . 1991; 64 861-866
28 Sutcliffe J S, Nelson D L, Zhang R. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet . 1992; 1 397-400
29 Chudley A E, Hagerman R J. Fragile X syndrome. J Pediatr . 1987; 110 821-831
30 Turner G, Webb T, Wake S, Robinson H. Prevalence of fragile X syndrome. Am J Med Genet . 1996; 64 196-198
31 deVries B BA, Mohkamsing S, van den Ouweland M W A. Screening for the fragile X syndrome among the mentally retarded: a clinical study. J Med Genet . 1999; 36 467-471
32 Jacobs P A, Sherman S L. The fragile(X): a marker for the Martin-Bell syndrome. Dis Markers . 1985; 3 9-25
33 Sherman S L, Morton N E, Jacobs P A, Turner G. The marker(X) syndrome: a cytogenetic and genetic analysis. Ann Hum Genet . 1984; 48 21-37
34 Sherman S L, Jacobs P A, Morton N E. Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet . 1985; 69 289-299
35 Sherman S L, Rogatko A, Turner G. Recurrence risks for relatives in families with an isolated case of the fragile X syndrome. Am J Med Genet . 1988; 31 753-765
36 Fisch G S, Snow K, Thibodeau S N. The fragile X premutation in carriers and its effect on mutation size in offspring. Am J Hum Genet . 1995; 56 1147-1155
37 Heitz D, Devys D, Imbert G, Kretz C, Mandel J-L. Inheritance of the fragile X syndrome: size of the fragile X premutation is a major determinant of the transition to full mutation. J Med Genet . 1992; 29 794-801
38 Taylor A K, Safanda J F, Fall M Z. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome. JAMA . 1994; 271 507-514
39 Sobesky W E, Taylor A K, Pennington B F. Molecular/clinical correlations in females with fragile X. Am J Med Genet . 1996; 64 340-346
40 Cronister A, Schreiner R, Wittenberger M, Amiri K, Harris K, Hagerman R J. Heterozygous fragile X female: historical, physical, cognitive, and cytogenetic features. Am J Med Genet . 1991; 38 269-274
41 Schwartz C E, Dean J, Howard-Peebles P N. Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am J Med Genet . 1994; 51 400-402
42 Partington M W, Moore D Y, Turner G M. Confirmation of early menopause in fragile X carriers. Am J Med Genet . 1996; 64 370-373
43 Allingham-Hawkins D J, Babul-Hirji R, Chitayat D. Fragile X premutation is a significant risk factor for premature ovarian failure: The International Collaborative POF in Fragile X study: preliminary data. Am J Med Genet . 1999; 83 322-325
44 Vianna-Morgants A M, Costa S S, Pavanello R CM, Otto P A, Mingroni-Netto R C. Premature ovarian failure (POF) in Brazilian fragile X carriers. Genet Mol Biol . 1999; 22 471-474
45 Uzielli M LG, Guarducci S, Lapi E. Premature ovarian failure (POF) and fragile X premutation females: from POF to fragile X carrier identification, from fragile X carrier diagnosis to POF association data. Am J Med Genet . 1999; 84 300-306
46 Murray A, Ennis S, MacSwiney F, Webb J, Morton N E. Reproductive and menstrual history of females with fragile X expansions. Eur J Hum Genet . 2000; 8 247-252
47 Murray A, Webb J, MacSwiney F, Shipley E L, Morton N E, Conway G S. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women. Hum Reprod . 1999; 14 1217-1219
48 Conway G S, Hettiarachchi S, Murray A, Jacobs P A. Fragile X premutations in familial premature ovarian failure. Lancet . 1995; 346 309-310
49 Conway G S, Payne N N, Webb J, Murray A, Jacobs P A. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod . 1998; 13 1184-1188
50 Murray A, Webb J, Grimley S, Conway G, Jacobs P. Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet . 1998; 35 637-641
51 Marozzi A, Vegetti W, Manfredini E. Association between idiopathic premature ovarian failure and fragile X premutation. Hum Reprod . 2000; 15 197-203
52 Rousseau F, Rouillard P, Morel M-L, Khandjian E W, Morgan K. Prevalence of carriers of premutation-size alleles of the FMR1 gene and implications for the population genetics of the fragile X syndrome. Am J Hum Genet . 1995; 57 1006-1018
53 Sherman S L. The high prevalence of fragile X premutation carrier females: is this frequency unique to the French Canadian population?. Am J Hum Genet . 1995; 57 991-994
54 Kenneson A, Cramer D W, Warren S T. Fragile X premutations are not a major cause of early menopause. Am J Hum Genet . 1997; 61 1362-1370
55 Marozzi A, Dalpra L, Ginelli E. FRAXA premutations are not a cause of familial premature ovarian failure. Hum Reprod . 1999; 14 573-574
56 Patsalis P C. FMR1 repeat analysis in patients with ovarian dysfunction or failure. Am J Med Genet . 1999; 83 329-334
57 Bulmer M G. The frequency of twins: maternal age and parity. In: The Biology of Twinning in Man London: Oxford University Press 1970: 74-83
58 Martin N G, Healey S C, Pangan T S, Heath A C, Turner G. Do mothers of dizygotic twins have earlier menopause: a role for fragile X?. Am J Med Genet . 1997; 69 114-116
59 Fryns J-P. The female and the fragile X: a study of 144 obligate female carriers. Am J Med Genet . 1986; 23 157-169
60 Turner G, Robinson H, Wake S, Martin N. Dizygous twinning and premature menopause in fragile X syndrome. Lancet . 1994; 344 1500
61 Vianna-Morgante A M. Twinning and premature ovarian failure in premutation fragile X carriers. Am J Med Genet . 1999; 83 326
62 Healey S C, Duffy D L, Martin N G, Turner G. Is fragile X syndrome a risk factor for dizygotic twinning?. Am J Med Genet . 1997; 72 245-247
63 Sherman S L, Meadows K L, Ashley A E. Examination of factors that influence the expansion of the fragile X mutation in a sample of conceptuses from known carrier females. Am J Med Genet . 1996; 64 256-261
64 Sherman S L, Turner G, Sheffield L, Laing S, Robinson H. Investigation of the twinning rate in families with the fragile X syndrome. Am J Med Genet . 1988; 30 625-631
65 Lyon M F. The X inactivation centre and X chromosome imprinting. Eur J Hum Genet . 1994; 2 255-261
66 Belmont J W. Genetic control of X inactivation and processes leading to X-inactivation skewing. Am J Hum Genet . 1996; 58 1101-1109
67 Gale R E, Wheadon H, Boulos P, Linch D C. Tissue specificity of X-chromosome inactivation patterns. Blood . 1994; 83 2899-2905
68 Hundscheid R DL, Sistermans E A, Thomas C MG. Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations. Am J Hum Genet . 2000; 66 413-418
69 Hundscheid R DL, Thomas C MG, Braat D DM, Oostra B A, Smits A PT. Reply to the letters from Murray et al and Vianna-Morgante and Costa. Am J Hum Genet . 2000; 67 256-258
70 Murray A, Ennis S, Morton N. No evidence for parent of origin influencing premature ovarian failure in fragile X premutation carriers. Am J Hum Genet . 2000; 67 253-254
71 Vianna-Morgante A M, Costa S S. Premature ovarian failure is associated with maternally and paternally inherited premutation in Brazilian families with fragile X. Am J Hum Genet . 2000; 67 254-255
72 Sherman S L. Premature ovarian failure among fragile X premutation carriers: parent-of-origin effect?. Am J Hum Genet . 2000; 67 11-13
73 Syrrou M, Georgiou I, Patsalis P C, Bouba I, Adonakis G, Papoulatos G N. Fragile X premutations and (TA)n estrogen receptor polymorphism in women with ovarian dysfunction. Am J Med Genet . 1999; 84 306-308
74 Fisch G, Kenneson A, Warren S, Zelterman D. Evidence of linkage disequilibrium between POF1 and FRAXAC1. Am J Hum Genet . 1998; 63(Suppl) A212
75 Feng Y, Zhang F, Lokey L K. Translational suppression by trinucleotide repeat expansion at FMR-1 Science . 1995; 268 731-734
76 Tassone F, Hagerman R J, Taylor A K, Gane L W, Godfrey T E, Hagerman P J. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet . 2000; 66 6-16
77 Davis B M, Mccurrach M E, Taneja K L, Singer R H, Housman D E. Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc Natl Acad Sci U S A . 1997; 94 7388-7393
78 Philips A V, Timchenko L T, Cooper T A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science . 1998; 280 737-740
79 Singer R H. Triplet-repeat transcripts: a role for RNA in disease. Science . 1998; 280 696-698
80 Timchenko L T, Timchenko N A, Caskey C T, Roberts R. Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy. Hum Mol Genet . 1996; 5 115-123
81 Timchenko L T. Human genetics '99: trinucleotide repeats. Myotonic dystrophy: the role of RNA CUG triplet repeats. Am J Hum Genet . 1999; 64 360-364
82 Bachner D, Manca A, Steinbach P. Enhanced expression of the murine Fmr1 gene during germ cell proliferation suggests a special function in both the male and the female gonad. Hum Mol Genet . 1993; 2 2043-2050
83 Braat D DM, Smits A PT, Thomas C MG. Menstrual disorders and endocrine profiles in fragile X carriers prior to 40 years of age: a pilot study. Am J Med Genet . 1999; 83 327-331